key: cord-1051502-fsuav3oe
authors: Wu, Fuqing; Xiao, Amy; Zhang, Jianbo; Moniz, Katya; Endo, Noriko; Armas, Federica; Bonneau, Richard; Brown, Megan A.; Bushman, Mary; Chai, Peter R.; Duvallet, Claire; Erickson, Timothy B.; Foppe, Katelyn; Ghaeli, Newsha; Gu, Xiaoqiong; Hanage, William P.; Huang, Katherine H.; Lee, Wei Lin; Matus, Mariana; McElroy, Kyle A.; Nagler, Jonathan; Rhode, Steven F.; Santillana, Mauricio; Tucker, Joshua A.; Wuertz, Stefan; Zhao, Shijie; Thompson, Janelle; Alm, Eric J.
title: SARS-CoV-2 RNA concentrations in wastewater foreshadow dynamics and clinical presentation of new COVID-19 cases
date: 2021-09-04
journal: Sci Total Environ
DOI: 10.1016/j.scitotenv.2021.150121
sha: 4a265c451c8997de00710d33656c8b15ba733307
doc_id: 1051502
cord_uid: fsuav3oe

Current estimates of COVID-19 prevalence are largely based on symptomatic, clinically diagnosed cases. The existence of a large number of undiagnosed infections hampers population-wide investigation of viral circulation. Here, we quantify the SARS-CoV-2 concentration and track its dynamics in wastewater at a major urban wastewater treatment facility in Massachusetts, between early January and May 2020. SARS-CoV-2 was first detected in wastewater on March 3. SARS-CoV-2 RNA concentrations in wastewater correlated with clinically diagnosed new COVID-19 cases, with the trends appearing 4–10 days earlier in wastewater than in clinical data. We inferred viral shedding dynamics by modeling wastewater viral load as a convolution of back-dated new clinical cases with the average population-level viral shedding function. The inferred viral shedding function showed an early peak, likely before symptom onset and clinical diagnosis, consistent with emerging clinical and experimental evidence. This finding suggests that SARS-CoV-2 concentrations in wastewater may be primarily driven by viral shedding early in infection. This work shows that longitudinal wastewater analysis can be used to identify trends in disease transmission in advance of clinical case reporting, and infer early viral shedding dynamics for newly infected individuals, which are difficult to capture in clinical investigations.

The ongoing coronavirus disease pandemic, caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has quickly become a global health crisis, with over 2 million confirmed cases in the US and 7.4 million worldwide as of June 11, 2020(Johns Hopkins University Center for Systems Science and Engineering, 2020) . Due to limited diagnostic capacity in many countries and high rates of asymptomatic individuals (Gandhi et al., 2020; Mizumoto et al., 2020) , these numbers are considered to be underestimates of the true prevalence of infection (Kaashoek and Santillana, 2020; Lu et al., 2021) .

Wastewater surveillance has been used to detect illicit drug consumption, human health-related biomarkers, and infectious diseases including SARS-CoV-2. It offers a complementary approach to clinical disease surveillance to track viral outbreak and circulation in the population (Daughton, 2018; Fuschi et al., 2021; Lodder and Husman, 2020; Mao et al., 2020; Sims and Kasprzyk-Hordern, 2020 ). In addition, wastewater surveillance provides an unbiased sample of the infected population, including asymptomatic and pre-symptomatic individuals, those who are symptomatic but have not yet been clinically confirmed, and individuals who may have the disease but do not seek healthcare. Early work has shown that wastewater surveillance could detect SARS-CoV-2 before it became widespread in a population, and that viral levels in wastewater largely paralleled local increases in clinical cases of COVID-19 in Australia (Ahmed et al., 2020a) , France (Wurtzer et al., 2020) , the Netherlands (Medema et al., 2020) , Spain (Orive et al., 2020; Randazzo et al., 2020) , Turkey (Kocamemi et al., J o u r n a l P r e -p r o o f

The 24-h composite samples of raw sewage were collected from the Deer Island Wastewater Treatment Plant in Massachusetts. The January, February and early March samples were stored at 4°C in the wastewater treatment facility before being transferred to the laboratory on ice in a second container. Those samples were received in two groups and processed on April 17 and 21, respectively, and the longest storage time at 4°C was 97 d (January 14 to April 21) before analysis. Samples from mid-March to May were received in six groups in the order of time and processed as previously described . Their storage time at 4°C varied from 1 to 34 d. Briefly, samples were pasteurized at 60°C for 90 min to inactivate the virus. Previous studies showed that pasteurization has little influence on the detection of SARS-CoV-2 RNA copies, and PMMoV is highly resistance to heat inactivation (Auerswald et al., 2021; Pastorino et al., 2020; Shirasaki et al., 2020; . Raw sewage was then vacuum filtered through a 0.2 µm membrane (Millipore Sigma) to remove bacterial cells and debris. Filtrate was used for the viral enrichment with the methods described below.

Two methods were used for RNA extraction, reverse transcription and quantitative PCR (Methods I and II) . For Method I, the filtrate (40 ml) was mixed with 4 g of Polyethylene glycol 8000 (10% w/v, Millipore Sigma) and 0.9 g NaCl (0.3 M, Millipore Sigma) and centrifuged at 12,000 xg at 4°C for 2 hours (or overnight centrifugation at 3,200 xg) to precipitate the viral particles. The viral pellet was then resuspended in 1.5 ml Trizol reagent (Cat# 15596026, Thermo Fisher Scientific) for RNA extraction. cDNA was synthesized by reverse transcription (RT) based on the manufacturer's protocol (M0368, J o u r n a l P r e -p r o o f Journal Pre-proof New England Biosciences). Briefly, 10 µl of RNA was mixed with random hexamers and then incubated at 70°C for 5 min and 4°C for 3 min. After that, the RNA-hexamer mixture was mixed with 5X ProtoScript II buffer (5 µl), 0.1 M DTT (2.5 µl), ProtoScript II Reverse Transcriptase (200 U/µl. 1.25 µl), 10 mM dNTP (1.25 µl), RNase Inhibitor (40 U/µl, 0.5 µl), and Nuclease-free water (2.5 ul) to a total volume of 25 µl. The mixture was then incubated at 42°C for 1 hour and inactivated at 65°C for 20 minutes.

The quantitative PCR (qPCR) was performed with TaqMan assay techniques. Briefly, the TaqMan® Fast Advanced Master Mix (4444557, ThermoFisher Scientific) was mixed with the primers and water, and then distributed into the 96-well PCR plate. 2 µl of cDNA template from RT was added into the plate, which was sealed with adhesive PCR plate seals (AB0558, ThermoFisher Scientific). The qPCR reaction was carried out for 48 cycles using Bio-Rad CFX96 Real-Time PCR Detection System based on the following program: polymerase activation (95°C for 2 min), PCR (48 cycles, denature at 95°C for 1 s, and anneal/extend at 55°C for 30 s).

The primers (N1 and N2) and DNA standards of SARS-CoV-2 nucleocapsid (N) gene were used to quantify the genome copies of SARS-CoV-2 (Table S1, Ref.(CDC, 2020) ).

Briefly, Cq values for N1 or N2 primer sets were first converted to viral gene copies in the cDNA sample (copies per µl of cDNA) based on the calibration curves established with the positive control plasmid (Table S1 ). This concentration was further converted to viral gene copies per microliter of the wastewater sample by multiplying the dilution factor (volume of total cDNA * total volume of RNA / (volume of RNA used for reverse transcription * starting volume of filtered wastewater sample)). Two or three replicates were performed for each primer set, and mean values were reported. The MIQE J o u r n a l P r e -p r o o f Journal Pre-proof (Minimum Information for Publication of Quantitative Real-Time PCR Experiments) checklist was also provided as supplementary information (Table S1) .

Concentrations of fecal materials in wastewater are subject to wide fluctuations in daily sewage flow rates at the wastewater treatment plant. To correct for these fluctuations, we used pepper mild mottle virus (PMMoV), a positive-strand RNA virus prevalent in human feces (Hamza et al., 2019; Rosario et al., 2009; Zhang et al., 2005) , as an internal reference for quantification. PMMoV is globally distributed and highly stable in the wastewater (Hamza et al., 2019; Kitajima et al., 2018; Rosario et al., 2009; Zhang et al., 2005) . Our previous results showed that PMMoV is relatively stable across samples, and the data after PMMoV adjustment are much less noisy and match the upward trend of clinical COVID-19 cases . Briefly, we used qPCR to evaluate the PMMoV concentrations across the sewage samples in our time-series with the PMMoV primers and probe (Table S1, Ref. Zhang et al., 2005) . Results showed that PMMoV is detectable and relatively stable between daily samples, with a standard deviation of 1.789 Ct in the 108 tested samples ( Figure S8 ).

To adjust the SARS-CoV-2 viral concentrations for each sample, we first calculated the deviation of its PMMoV copies from the median of PMMoV copies in all 108 samples: Deviation factor = 10^(k * (sample Ct -median Ct)), where k=-0.2991 is the slope of the standard curve (amplification efficiency is 99.11% for this primer set as previously measured ). The SARS-CoV-2 viral concentration was then divided by this deviation.

In Method I, we processed 108 wastewater samples, in batches as they were received in the lab, from January 8 to May 5, 2020 ( Figure S1 ).

For Method I, raw wastewater samples were processed as they were received, in Viral gene copies per ml of sewage were converted from the Ct values for N1 or N2 primer sets using the calibration curves (Table S1) , and multiplied by the dilution factor J o u r n a l P r e -p r o o f (Total volume of RNA sample / Starting volume of filtered wastewater sample). Two technical replicates were performed for each primer set, and mean values were reported. No significant difference was found between the viral gene concentrations in the wastewater estimated from N1 or N2 primer sets (Student's t-test with a p-value 0.407). PMMoV was also quantified in the newly extracted samples, and SARS-CoV-2 RNA concentrations were adjusted by the corresponding PMMoV concentrations in the sample using the method described above. Data analysis was performed with both raw and PMMoV normalized viral concentrations to confirm agreement of observed trends. Viral genome copies per ml of wastewater sample were averaged from the N1 and N2 primer sets.

To assess the robustness of Method I and Method II, we evaluated the recovery rate using murine hepatitis virus (MHV, ATCC® VR-764), which is also an enveloped coronavirus like SARS-CoV-2. SARS-CoV-2 virus was not used due to safety reasons.

Briefly, MHV was spiked into the wastewater and then concentrated by PEG8000 and Amicon filter in Method I and Method II, respectively. In parallel, the same amount of virus was directly lysed using Trizol reagent or AVL buffer in Method I and Method II, respectively. Viral RNA extraction, RT, and qPCR were performed by following the steps as described above using MHV-specific primers and probes (Table S1) . Results indicate that the recovery rates of viral concentration in Method I and Method II were 58.09±20.21% and 31.42±2.59%, respectively. Using the same protocol, Ahmed et al.

obtained recovery rates ranging from 26.7 to 65.7% (Ahmed et al., 2020b) .

J o u r n a l P r e -p r o o f All data presented was obtained with Method II, unless specified otherwise. The longitudinal data generated with Method I are only presented in Figure 1B , Figure S1 and S9, showing high correspondence of viral concentrations obtained from the two methods. In Method II, we reprocessed 52 samples from March 3 to May 5, and 8 new samples from May 2 to May 20. In total, 116 samples were processed in this study from January 8 to May 20.

Clinical case data from March 1, 2020 to May 20, 2020 from Norfolk, Suffolk, and Middlesex Counties was downloaded from Mass.gov("Department of Public Health | Mass.gov," 2020). We summed the clinical cases from each county to represent the cases in the sewershed of the wastewater treatment plant and calculated the new cases per day. We conducted locally weighted scatterplot smoothing (LOWESS) of wastewater concentrations (smoothing parameter = 0.4) and new clinical cases (smoothing parameter = 0.2) purely to show the qualitative trends in Figure 1A . No further analysis was done with the smoothed data. LOWESS smoothing was done with statsmodels.nonparametric.smoothers_lowess.lowess in python 3.6.5 and statsmodels 0.9.0.

Pearson's correlation was calculated between unsmoothed wastewater data and unsmoothed clinical data. Higher correlations were seen when comparing wastewater data to daily new clinical cases than to cumulative cases ( Figure 1C and Figure Citymapper("Citymapper Mobility Index," 2020), respectively. Supermarket visits data for Massachusetts was downloaded from SafeGraph(SafeGraph, 2020).

For analysis of emotional content, we used the dictionaries from LIWC2015 (Tausczik and Pennebaker, 2010) , which are optimized to capture social and psychological states within written text. Our analysis focused specifically on health, anxiety, and deathrelated texts. For analysis, the available text fields from the Facebook posts were pre-processed, and psychometrics were calculated using the prevalence of words in the LIWC2015 dictionaries within the corpus of posts for a given day. Counts of words related to anxiety, death, and health were retained for analysis. The prevalence of posts about anxiety, death, and health by day was calculated by summing the counts of word matches and dividing by the number of posts in that day.

describing the average viral shedding detectable in wastewater from infected individuals in the sewershed. We assume I(t) = z * G(t), where G(t) represents governmentreported new cases, while z represents the ratio between non-reported and reported cases. We chose z = 1, 6, 24 based on a CDC report that the estimated number of total infections based on serological testing could be 6-24x higher than reported cases (Havers et al., 2020) .

We hypothesized that the viral shedding function S(t) could be fit by a beta distribution with parameters α, β, and scaling factor c. Beta and gamma distributions harbor a rich variety of shapes with only two parameters, and are widely employed to model viral shedding or viral load dynamics from clinical data (Ferretti et al., 2020; He et al., 2020;  J o u r n a l P r e -p r o o f Huynh and Rong, 2012; Milbrath et al., 2013) . Since the beta distribution is defined on the range [0, 1], we sampled the probability density function for points 1/30 apart as a proxy for viral shedding over 30 days. Time lag between wastewater data and clinical counts was denoted as parameter τ. Based on the results of the correlation analysis, we back-dated the clinical cases by τ = 4 days to get the new cases per day function I(t).

The full model is:

The discrete convolution formula is defined as: ) ∑ and beta probably density function is defined as:

, where is the gamma function ) ∫ .

We defined the score function as the sum of squared errors (SSE) between log10(observed copies/ml in wastewater) and log10((S * I) [t] ). We used the L-BFGS method in the scipy.optimize.minimize function to find parameters α, β, c of the beta distribution that minimized the SSE, which is equivalent to conducting maximum likelihood estimation under the assumption of normally distributed homoscedastic noise. To investigate the relationship between the shape of the shedding function and the clinical time lag τ, we conducted the optimization for τ ranging from 0-10 days and reported the optimal shedding function for each τ. This analysis was performed for northern and southern influent data separately, as well as the average wastewater data.

We also modeled the shedding function as a gamma distribution over [0, 30] and had similar results as with the beta distribution. All shedding estimation work was done with python 3.6.5, numpy 1.14.3, pandas 0.23.0, and scipy 1.1.0.

MCMC simulation was performed to investigate the uncertainty landscape around the maximum likelihood estimation of the parameters for the viral shedding function. Briefly, we started at the maximum likelihood estimate for each parameter α, β, and c. We defined the transition function as a normal distribution centered around the previous parameters, with standard deviation (1, 1, 0.001) for α, β, and c, respectively. At each iteration, we selected a new set of parameters using the transition function and computed the log likelihood. New parameters were accepted if the log likelihood was higher. If the log likelihood was lower, we accepted the parameters with probability exp(-J o u r n a l P r e -p r o o f delta(SSE)/T), where we used T = 5 to tune the acceptance ratio. In 10,000 iterations, 1,318 samples were accepted. We selected 100 random selected parameter sets and plot them in Figure 1E and 1F to illustrate the uncertainty around the maximum likelihood estimate of the shedding function. MCMC simulation was done with python 3.6.5, numpy 1.14.3, pandas 0.23.0, and scipy 1.1.0.

We SARS-CoV-2 was consistently detected at comparable levels, and demonstrated similar dynamics, in the northern and southern influents ( Figure 1B ).

Since SARS-CoV-2 was first detected in wastewater when only two cases were clinically confirmed, we hypothesized that the wastewater data included a significant undiagnosed, COVID-19 infected population. This difference between wastewater and clinical data could be due to underdiagnosis of asymptomatic or mildly symptomatic cases, limitations in clinical testing capacity, or a time delay between viral shedding and the onset of respiratory and other symptoms.

We tested the correlation of viral concentrations with new clinical cases and cumulative cases, allowing for a variable time lag ( Figure 1C /D and Figure S2 ). The number of cumulative cases was considered because of reports that SARS-CoV-2 can be shed in J o u r n a l P r e -p r o o f feces for more than 20 days, in which case the long tail of shedding may contribute significant signal to wastewater (Wölfel et al., 2020; Zheng et al., 2020) . Higher correlations were seen when comparing wastewater data to daily new clinical cases than to cumulative cases ( Figure 1C and Figure S2 ). Strong correlations (Pearson's r > 0.8) were observed when comparing new clinical cases back-dated by 3-5 and 9-10 days, and the maximum agreement between the two time series was observed for a time offset of 4 days (Pearson's r = 0.88, Figure 1C /D). Similar results were found when each sewershed was considered individually ( Figure S3 ). This time lag between the wastewater signal and clinically reported cases is consistent with the typical 4-5 day incubation period from SARS-CoV-2 infection to symptom onset Lauer et al., 2020; Li et al., 2020) . Thus, wastewater surveillance could potentially be used to predict trends in new COVID-19 cases.

The high correlation between wastewater viral concentrations and daily reports of new clinically confirmed COVID-19 cases ( Figure 1D )combined with the time lag between the wastewater signal and clinical datasuggests that newly infected individuals contribute significant viral loads to the wastewater and that most of this shedding may occur early in infection, prior to the individual seeking healthcare and being tested. As a result, viral dynamics in wastewater could provide insight into early shedding, which would be challenging to capture clinically if it precedes patient presentation to the clinic. Modeling revealed a short burst of viral shedding that peaked around day 2 of shedding and lasted for 3-4 days ( Figure 1E and1F ). This feature of the modeling was robust to different time lags (0-10 days) applied to data of daily new clinical cases, as well as the distribution used to fit the shedding function (both beta and gamma distributions were investigated, Figure S4 ). This short burst of shedding was also seen after modeling each sewershed individually ( Figure S5-6) . Inferring the viral shedding function using values for z (estimated true number of infected individuals) reflecting 6x or 24x the reported number of new cases (Havers et al., 2020) resulted in a similar narrow-peaked viral shedding function peaking around day 2, but with a lower average magnitude per individual ( Figure 1E ). The lower magnitude of viral shedding is expected because W(t)

A limitation to this modeling method is that the trends inferred from Boston data early in the pandemic may be confounded by limited testing capacity. To address this limitation and validate our findings, we have repeated our analysis with wastewater and clinical J o u r n a l P r e -p r o o f new case data, collected over an additional 9 month period, from August 15, 2020 to

New Initiatives to Stop Spread of COVID-19 | Mass.gov," n.d.). Using this second data set, we found a similar narrow-peaked viral shedding function during the early phase of infection ( Figure S7 ), replicating our initial findings. These independent models of the two waves of the COVID-19 pandemic showed similar results, improving our confidence that Boston municipal wastewater data reflects an early period of viral shedding, in alignment with clinical reports. As additional groups test this methodology it will be useful to compare results to understand the factors underpinning trends in different types of wastewater.

The early timing of the inferred shedding is consistent with reports that viral load and infectiousness may peak before symptom onset (Benefield et al., 2020; He et al., 2020; Wei, 2020) , and that fecal and respiratory shedding may occur 3-5 days before symptom onset D. Wang et al., 2020, p. 138) . Although the early peak of viral shedding in our model does not directly reflect patients' reported clinical courses, it is consistent with reports of abdominal pain, nausea, and diarrhea preceding onset of respiratory symptoms in COVID-19 patients (Cholankeril et al., 2020; Dane et al., 2020; Siegel et al., 2020) , suggesting that individuals may shed SARS-CoV-2 virus early in this process. In several clinical studies, the earliest stool samples collected have been positive for viral RNA (day 3 post symptom onset (Wölfel et al., 2020) ; and day 0 of hospital admission 2)), suggesting fecal shedding may start data, and found that SARS-CoV-2 viral load peaks prior tonot atsymptom onset (Benefield et al., 2020) . Finally, a recent study modeled SARS-CoV-2 fecal shedding and found that hospitalized patients represent the tail end of shedding and their shedding levels cannot explain the high RNA concentrations observed in wastewater (Hoffmann and Alsing, 2021) . This modeling result is consistent with ours and suggests the presence of more abundant shedding early in infection.

The inferred peak shedding was generally several orders of magnitude greater than typical values (10 4 -10 9 copies per 200 g stool), which are measured after symptom onset and clinical testing Wölfel et al., 2020; Jones et al., 2020) ( Figure 1E ). In a more recent study, Han et al. measured the viral RNA load in infected individuals in South Korea and found the median fecal RNA load was 10 7.68 (ranging from 10 4.1 -10 10.27 ) copies/ml Together, our data suggest that SARS-CoV-2 levels in wastewater may be largely driven by an early burst of shedding, followed by a period of prolonged low-level shedding as reported in the literature Hoffmann and Alsing, 2021; Wölfel et al., 2020; Zheng et al., 2020) . Figure 1A ) that began in the following days.

Although wastewater data should be relatively unbiased, relatively high day-to-day variation in our results suggests that they are noisy. On the other hand, clinical data may be less noisy but more prone to systematic bias due to constraints such as limited clinical testing capacity. Together, these independent data streams from clinical-and wastewater-based surveillance can provide a more complete picture of viral dynamics, and a new opportunity to explore the relationship between COVID-19 dynamics and J o u r n a l P r e -p r o o f concomitant public health interventions and behavioral changes. In this study, we infer a viral shedding function that can help to connect these two data streams in a quantitative fashion to allow for more accurate epidemiological modelingand ultimately, more informed decision-making about how and when to intervene.

Several knowledge gaps introduce uncertainty to our modeling approaches. First, viral concentrations in wastewater are highly dependent on individual shedding rates, viral stability in wastewater, and flow rates of the influent. While we have noted that normalization with the human fecal indicator PMMoV helps reduce noise due to sampling time and flow, significant uncertainties remain regarding the consistency of viral shedding among COVID-19 patients Zheng et al., 2020) .

Second, the viral shedding profile inferred by our modeling approach relies on reported clinical new cases over the course of the pandemic, and is thus subject to the limitations of clinical testing criteria and capacity ( Figure 2 ). This early lack of testing is especially evident given that SARS-CoV-2 was detectable in wastewater when there were only 2 reported cases in the sewershed, which is certainly underreported and would decrease the robustness of the model ( Figure 1A ). However, our finding of a narrow-peaked viral shedding function was confirmed when repeating the modeling with data after August 15, 2020, when clinical testing capacity was well established in Massachusetts, lending more confidence to this result. Third, the exact percentage of asymptomatic infections in the sewershed remains unknown. We here incorporated z to reflect an estimate of the true number of infections into our model and analyzed when z equals 6 or 24x the J o u r n a l P r e -p r o o f clinically reported cases based on serological reports (Havers et al., 2020) . We recognize that z may be a function of disease spread and clinical testing capacity.

Fourth, the wastewater viral concentrations reported were not corrected for viral RNA degradation in sewage lines and during sample storage at 4°C or losses during experimental procedures. In this study, some samples were stored for up to 2.5 months at 4°C before being reprocessed with Method II. We compared the SARS-CoV-2 RNA concentrations measured by Method I and Method II. As shown in Figure S9A , the general magnitude and trends of SARS-CoV-2 concentrations were similar between the two methods, and samples detected positive in Method I were also positive in Method II.

These results indicated that SARS-CoV-2 is not highly degraded during storage, which is consistent with previous work reporting that SARS-CoV-2 copy numbers were stable at 4°C for one to three months (Hokajärvi et al., 2021) . We also compared PMMoV concentrations in January, February, and March wastewater samples, which were stored at 4°C for 1 to 97 d before processed in April. No significant difference was found between those samples by month ( Figure S9B ). Together, these results suggested that SARS-CoV-2 and PMMoV were not highly degraded after storage at 4°C for up to three months. However, further experiments using live SARS-CoV-2 viral stocks of known concentrations to quantify the degradation rate and recovery efficiency from wastewater samples would improve our model inference. 

In this study, we used longitudinal wastewater surveillance to track the appearance and J o u r n a l P r e -p r o o f

The data presented in the figures, and the code for the analysis, and that support the other findings of this study are available from the corresponding author on reasonable request. The code used for the analysis will be released as soon as the paper is published. 

First confirmed detection of SARS-CoV-2 in untreated wastewater in Australia: A proof of concept for the wastewater surveillance of COVID-19 in the community

Comparison of virus concentration methods for the RT-qPCR-based recovery of murine hepatitis virus, a surrogate for SARS-CoV-2 from untreated wastewater

Assessment of inactivation procedures for SARS-CoV-2

Administration Announces New Initiatives to Stop Spread of COVID-19 | Mass.gov [WWW Document

The pathogenicity of SARS-CoV-2 in hACE2 transgenic mice

Detection of SARS-CoV-2 variants by genomic analysis of wastewater samples in Israel

SARS-CoV-2 viral load peaks prior to symptom onset: a systematic review and individualpooled analysis of coronavirus viral load from 66 studies

Research Use Only 2019-Novel Coronavirus (2019-nCoV) Real-time RT-PCR Primers and Probes [WWW Document

FluView: National, Regional, and State Level Outpatient Illness and Viral Surveillance [WWW Document

The presence of SARS-CoV-2 RNA in the feces of COVID-19 patients

High Prevalence of Concurrent Gastrointestinal Manifestations in Patients With Severe Acute Respiratory Syndrome Coronavirus 2: Early Experience From California

Citymapper Mobility Index

CrowdTangle Team, 2020. Facebook

Unexpected Findings of Coronavirus Disease (COVID-19) at the Lung Bases on Abdominopelvic CT

Monitoring wastewater for assessing community health: Sewage Chemical-Information Mining (SCIM)

Quantifying SARS-CoV-2 transmission suggests epidemic control with digital contact tracing

Wastewater-Based Epidemiology for Managing the COVID-19 Pandemic

Asymptomatic Transmission, the Achilles' Heel of Current Strategies to Control Covid-19

Clinical Characteristics of Coronavirus Disease 2019 in China

Pepper mild mottle virus in wastewater in Egypt: a potential indicator of wastewater pollution and the efficiency of the treatment process

Viral RNA Load in Mildly Symptomatic and Asymptomatic Children with COVID-19

Seroprevalence of Antibodies to SARS-CoV-2 in 10 Sites in the United States

Temporal dynamics in viral shedding and transmissibility of COVID-19

Faecal shedding models for SARS-CoV-2 RNA amongst hospitalised patients and implications for wastewater-based epidemiology

The detection and stability of the SARS-CoV-2 RNA biomarkers in wastewater influent in Helsinki

Modeling the dynamics of virus shedding into the saliva of Epstein-Barr virus positive individuals

COVID-19) | Mass.gov [WWW Document

Map -Johns Hopkins Coronavirus Resource Center

Shedding of SARS-CoV-2 in feces and urine and its potential role in person-to-person the environment-based spread of COVID-19

COVID-19 Positive Cases, Evidence on the Time Evolution of the Epidemic or An Indicator of Local Testing Capabilities? A Case Study in the United States (SSRN Scholarly Paper No. ID 3574849)

Pepper mild mottle virus as a water quality indicator

First Data-Set on SARS-CoV-2 Detection for Istanbul Wastewaters in Turkey

The Incubation Period of Coronavirus Disease 2019 (COVID-19) From Publicly Reported Confirmed Cases: Estimation and Application

Early Transmission Dynamics in Wuhan, China, of Novel Coronavirus-Infected Pneumonia

SARS-CoV-2 in wastewater: potential health risk, but also data source

Estimating the cumulative incidence of COVID-19 in the United States using influenza surveillance, virologic testing, and mortality data: Four complementary approaches

Can a Paper-Based Device Trace COVID-19 Sources with Wastewater-Based Epidemiology?

MBTA Gated Station Validations By Line

Presence of SARS-Coronavirus-2 RNA in Sewage and Correlation with Reported COVID-19 Prevalence in the Early Stage of the Epidemic in The Netherlands

Heterogeneity in norovirus shedding duration affects community risk

Estimating the asymptomatic proportion of coronavirus disease 2019 (COVID-19) cases on board the Diamond J o u r n a l P r e -p r o o f Princess cruise ship

Early SARS-CoV-2 outbreak detection by sewagebased epidemiology

Heat Inactivation of Different Types of SARS-CoV-2 Samples: What Protocols for Biosafety, Molecular Detection and Serological Diagnostics?

SARS-CoV-2 RNA in wastewater anticipated COVID-19 occurrence in a low prevalence area

Pepper Mild Mottle Virus as an Indicator of Fecal Pollution

The Impact of Coronavirus (COVID-19) on Foot Traffic

Suitability of pepper mild mottle virus as a human enteric virus surrogate for assessing the efficacy of thermal or free-chlorine disinfection processes by using infectivity assays and enhanced viability PCR

Lung Base Findings of Coronavirus Disease (COVID-19) on Abdominal CT in Patients With Predominant Gastrointestinal Symptoms

Future perspectives of wastewater-based epidemiology: Monitoring infectious disease spread and resistance to the community level

The Psychological Meaning of Words: LIWC and Computerized Text Analysis Methods

Outpatient Influenza-like Illness Surveillance Network (ILINet): Overall Percentage of Visits for ILI | CDC

Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China

Effective Heat Inactivation of SARS-CoV-2. medRxiv 2020.04.29

Presymptomatic Transmission of SARS-CoV-2 -Singapore

Virological assessment of hospitalized patients with COVID-2019. Nature 1-10

SARS-CoV-2 titers in wastewater are higher than expected from clinically confirmed cases. mSystems 5

Wastewater surveillance of SARS-CoV-2 across 40 U.S. states from February to

Prolonged presence of SARS-CoV-2 viral RNA in faecal samples

Evaluation of lockdown effect on SARS-CoV-2 dynamics through viral genome quantification in waste water

RNA Viral Community in Human Feces: Prevalence of Plant Pathogenic Viruses

Viral load dynamics and disease severity in patients infected with SARS-CoV-2 in Zhejiang province

2020). (F) PMMoV-adjusted viral concentrations), daily (orange line) and cumulative (brown line) confirmed cases along the secondary y-axis. Influenza Like Illness: Visits for influenza-like illness (ILI, purple shading) and confirmed flu cases (light green shading), and the difference between the two after normalization (purple line), which shows a peak of non-flu ILI at March 18. Clinical Testing: Daily SARS-CoV-2 tests and positive rates in MA. Hospitalizations and Deaths: New reported COVID-19 related deaths and hospitalizations in MA. Mobility: Public transit and cellular mobility data

Social Media: Facebook posts with terms expressing "Health

Fuqing Wu: Conceptualization; Methodology; Formal analysis; Investigation; Writing -Original Draft

Visualization Amy Xiao: Conceptualization; Methodology; Formal analysis; Investigation; Writing -Original Draft

Visualization Jianbo Zhang: Conceptualization; Methodology; Formal analysis; Investigation; Writing -Original Draft

Katya Moniz: Conceptualization; Writing -Original Draft; Project administration Noriko Endo: Investigation; Writing -review & editing Federica Armas: Validation

Writing -review & editing Mary Bushman: Writing -review & editing

Writing -review & editing

Writing -review & editing

Writing -review & editing

Katelyn Foppe: Investigation; Writing -review & editing Newsha Ghaeli: Writing -review & editing

Xiaoqiong Gu: Methodology; Validation; Writing -review & editing

Writing -review & editing; Supervision Katherine H Huang: Visualization; Writing -review & editing

Wei Lin Lee: Validation; Writing -review & editing

Mariana Matus: Funding acquisition; Resources

Resources; Writing -review & editing

Writing -review & editing Shijie Zhao: Writing -review & editing

Janelle Thompson: Conceptualization; Funding acquisition; Writing -review & editing

Supervision Eric J Alm: Conceptualization; Methodology; Funding acquisition

We thank the management and sampling team at the Massachusetts wastewater treatment facility who worked with us in providing the samples for analysis, in particular Ching Ng (National Environmental Agency, Singapore) for helpful discussion and for

J o u r n a l P r e -p r o o f